CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$2.01
-0.15 (-6.94%)
Open$2.33
Previous Close$2.16
Day High$2.34
Day Low$2.01
52W High$7.91
52W Low$0.97
Volume—
Avg Volume150.7K
Market Cap5.30M
P/E Ratio—
EPS$-3.38
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,543.3% upside
Current
$2.01
$2.01
Target
$33.03
$33.03
$21.42
$33.03 avg
$37.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.6K | 758.5K | 743.9K |
| Net Income | -11,167,385 | -209,998 | -203,473 |
| Profit Margin | -43,817.7% | -27.7% | -27.4% |
| EBITDA | -11,031,036 | -263,366 | -243,311 |
| Free Cash Flow | — | -217,938 | -231,433 |
| Rev Growth | — | -7.2% | +1.3% |
| Debt/Equity | 0.04 | 0.72 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $250.82 | +0.83% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $417.84 | +0.40% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.14 | +1.67% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $516.44 | -1.77% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $805.97 | +1.00% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.12 | +1.42% | 35.2 | 28.41B |